Skip to main content

Cancer and Aging

A Biological, Clinical, and Cultural Analysis

  • Chapter
Book cover Cancer, Culture, and Communication

Conclusions

Cancer will become the leading cause of morbidity and death as the global population ages. While health and health care disparities have been well documented in culturally and linguistically diverse patients with cancer, aging involves unique biological, medical, and social considerations that must be further explored as it also influences cancer prevention and cancer treatment in these populations. Further, even though aging is common to all cultures and latitudes, the cultural context in which the experience occurs varies even within the Western context. As such, cancer specialists must learn to not only account for the functional but also for the cultural diversity of the older population in medical decisions related to cancer prevention and cancer treatment. In addition, use of screening instruments such the CGA also represent a milestone in the management of older individuals. It is also currently being modified to become more cost effective and to provide more precise information related to life expectancy and tolerance of cancer treatment. The increase in cultural diversity in the oncology setting also influences cancer treatment. A clinician must be able to act within the boundaries of cultural competence when ministering to older cancer patients. Cultural specific instruments to assess older individuals are particularly desirable in a multicultural society, but also strive to effectively communicate with these individuals in these populations, their families and significant others. With proper patient selection and information, older individuals may obtain the same degree of benefits from cancer prevention and cancer treatment as younger individuals, and age should never be a criteria for health care discrimination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yancik R, Ries LAG. Aging and cancer in America: Demographic and epidemiologic perspectives. Hematol/Oncol Clin N Am. 2000;14:17–24.

    CAS  Google Scholar 

  2. Yancik RM, Ries L. Cancer and age: Magnitude of the problem. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology. London: Harwood Academic Publishers, 1998; 95–104.

    Google Scholar 

  3. Butow PN, Tattersall MH, Goldstein D. Communication with cancer patients in a culturally diverse society. Ann N Y Acad Sci 1997;809:317–329.

    CAS  PubMed  Google Scholar 

  4. Duthie E, Anisimov VN. Physiology of aging: Relevance to symptom perceptions: Age as a risk factor in multistage carcinogenesis. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology, 2nd ed. Amsterdam: Harwood Academic Publishers; 2003; in press.

    Google Scholar 

  5. Collins K. Mammalian telomeres and telomerase. Curr Opin Cell Biol. 2000;12:378–383.

    Article  CAS  PubMed  Google Scholar 

  6. Liggett WH, Sidransky D. Role of the P16 tumor suppressor gene in Cancer. J Clin Oncol. 1998;16:1197–1206.

    CAS  PubMed  Google Scholar 

  7. Anisimov VN. Age as a risk factor in multistage carcinogenesis. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology, 2nd ed. Amsterdam: Harwood Academic Publishers; 2003; in press.

    Google Scholar 

  8. Troen BR. The biology of aging. Mt Sinai J med. 2003;70(1):3–22.

    PubMed  Google Scholar 

  9. Campisi J. Cancer and age: The double-edged sword of proliferative senescence. J Am Ger soc. 1997;43:482–490.

    Google Scholar 

  10. Warner HR. Aging and regulation of apoptosis. Curr Top Cell Regul. 1997;35:107–121.

    CAS  PubMed  Google Scholar 

  11. Eskandari F, Sternberg EM. Neural-immune interactions in health and disease. Ann N Y Acad sci. 2002;966:20–27.

    CAS  PubMed  Google Scholar 

  12. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125–163.

    Article  CAS  PubMed  Google Scholar 

  13. Wilson CJ, Finch CE, Cohen HJ. Cytokines and Cognition —The case for a Head to Toe Inflammatory paradigm. JAm Ger soc. 2002;50:2041–2056.

    Google Scholar 

  14. Hamerman D, Berman JV, Albers W, et al. Emerging evidence of inflammation in conditions frequently affecting older adults: Reports of a symposium. J Am Ger Soc. 1999;47:1016–1102.

    CAS  Google Scholar 

  15. Ferrucci L, Penninx BWJH, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin 6 serum levels. J Am Ger soc. 2002;50:1947–1954.

    Google Scholar 

  16. Leng S, Chaves P, Koenig K, et al. Serum interleukin 6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: A pilot study. J Am Ger soc. 2002;50:1268–1271.

    Google Scholar 

  17. Chaves PH, Volpato S, Fried L. Challenging the world health organization criteria for anemia in the older woman. J Am Ger soc. 2001;49:S3, A10.

    Google Scholar 

  18. Reuben DR, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high functioning community dwelling older persons. J Am Ger soc. 2002;50:638–644.

    Google Scholar 

  19. Fees BS, Martin P, Poon LW. A model of loneliness in older adults. J Gerontol B Psychol Sci Soc sci. 1999:54:231–239.

    Google Scholar 

  20. Steverink N, Westerhof GJ, Bode C, et al. The personal experience of aging, individual resources, and subjective well being. J Gerontol B Psychol Sci Soc sci. 2001;56:P364–P373.

    CAS  PubMed  Google Scholar 

  21. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA. 2001;285:2987–2994.

    CAS  PubMed  Google Scholar 

  22. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 1998:279:1187–1193.

    Article  CAS  PubMed  Google Scholar 

  23. Ramos LR, Simoes EJ, Albert MS. Dependence in activities of daily living and cognitiver impairment strongly predict mortality in older urban residents in Brazil. J Am Ger soc. 2001;49:1168–1175.

    CAS  Google Scholar 

  24. Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–1587.

    CAS  PubMed  Google Scholar 

  25. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to the Eastern Cooperative group Performance Status in elderly cancer patients. An Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502.

    Article  PubMed  Google Scholar 

  26. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Int med. 1994;120:104–110.

    CAS  PubMed  Google Scholar 

  27. Yancik R, Ganz PA, Varricchio CG, et al. Perspectives on comorbidity and cancer in the older patient: approach to expand the knowledge base. J Clin Oncol. 2001; 19:1147–1151.

    CAS  PubMed  Google Scholar 

  28. Zagonel V, Fratino L, Piselli P, et al. The comprehensive geriatric assessment predicts mortality among elderly cancer patients. Proc Am Soc Clin Oncol. 2002;21:365 a (abstract 1458).

    Google Scholar 

  29. Chen H, Cantor A, Meyer J, et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003;15:1107–1114.

    Google Scholar 

  30. Extermann M, Chan H, Cantor AB. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002;38:1466–1473.

    Article  CAS  PubMed  Google Scholar 

  31. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36:453–471.

    Article  CAS  PubMed  Google Scholar 

  32. Balducci L. Epidemiologi of anemia in the elderly: information on diagnostic evaluation. J Am Ger soc. 2003;51(3 Suppl):S2–S9.

    Google Scholar 

  33. Chaves PH, Volpato S, Fried L. Challenging the world health organization criteria for anemia in the older woman. J Am Ger soc. 2001;49:S3, A10.

    Google Scholar 

  34. Littlewood TJ, Bajetta E, Nortier JW, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19(11):2865–2874.

    CAS  PubMed  Google Scholar 

  35. Schijvers D, Highley M, DeBruyn E, et al. Role of red blood cell in pharmakinetics of chemotherapeutic agents. Anticancer Drugs. 1999;10:147–153.

    Google Scholar 

  36. Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15(3):14–18.

    PubMed  Google Scholar 

  37. Wu Wc, Rathore SS, Wang Y, et al. Blood transfusions in elderly patients with acute myocardial infarction. N Eng J med. 2001;345:1230–1236.

    CAS  Google Scholar 

  38. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hemat-ocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999;33(6):1122–1130.

    CAS  PubMed  Google Scholar 

  39. Hamerman D: Toward an understanding of frailty. Ann Intern med. 1999;130:945–950.

    CAS  PubMed  Google Scholar 

  40. Balducci L, Stanta G. Cancer in the frail patient: a coming epidemic. Hematol Oncol Clin N Am. 2000;14:235–250.

    CAS  Google Scholar 

  41. Lyness JM, Ling DA, Cox C, et al. The importance of subsyndromal depression in older primary care patients. Prevalence and associated functional disability. J Am Ger soc. 1999;47:647–652.

    CAS  Google Scholar 

  42. Wholey MA, Simon GE. Managing depression in medical outpatient. N Engl J med. 2000;343:1942–1950.

    Google Scholar 

  43. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern med. 2001;134:345–360.

    CAS  PubMed  Google Scholar 

  44. Draper B. Attempted suicide in old age. Int J Geriatr Psychiatr. 1996;11:577–587.

    Google Scholar 

  45. Frierson RL. Suicide attempts by the old and the very old. Arch Intern med. 1991;151:141–144.

    Article  CAS  PubMed  Google Scholar 

  46. Yang CH, Tsai SJ, Chang JW, Hwang JP. Characteristics of Chinese suicide attempters admitted to a geropsychiatric unit. Int J Geriatr Psychiatr. 2001;16(11):1033–1036.

    Article  CAS  Google Scholar 

  47. Weitzner MA, Haley WE, Chen H. The family caregiver of the older cancer patient. Hematol Oncol Clin. 2000;14:269–282.

    CAS  Google Scholar 

  48. Hosaka T, Sugiyama Y. Structured intervention in family caregivers of the elemented elderly and changes in their immune function. Psychiatr Clin Neurosci. 2003;57(2):147–151

    Google Scholar 

  49. Jannsen I, Heymsfield SB, Ross R. Low relative skeletal mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Ger soc. 2002;50:889–896.

    Google Scholar 

  50. Visser M, Kitchevsky SB, Goodpaster BH, et al. Leg muscle mass in relation to lower extremity performance in men and women aged 70–79: the health, aging, and body composition study. J Am Ger soc. 2002;50:897–904.

    Google Scholar 

  51. Hu Peifeng, Seeman TE, Harris TB, et al. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur Study of successful Aging. J Am Ger soc. 2003;51:80–84.

    Google Scholar 

  52. Wedick NE, Barrett-Connor E, Knoke JD. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo Study. J Am Ger soc. 2002;50:1810–1815.

    Google Scholar 

  53. Astani A, Smith RC, Allen BJ. The predictive value of body proteins for chemotherapy induced toxicity. Cancer. 2000;88:796–903.

    Google Scholar 

  54. Guigoz Y, Vellas B, Garry PJ. Mininutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. In: Facts, Research, Interventions in Geriatrics. New York, Serdi Publishing Company, 1997;15–60.

    Google Scholar 

  55. Corcoran ME. Polypharmacy in the older patient. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic Publishers; 2003, in press

    Google Scholar 

  56. Clarfield AM, Bergman H, Kane R. Fragmentation of care for frail older people-an international problem. Experience from three countries: Israel, Canada, and the United States. J Am Ger soc. 2001;49:1714–1721.

    CAS  Google Scholar 

  57. Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric assessment. N Engl J med. 2002;346:905–912.

    Article  PubMed  Google Scholar 

  58. Reuben DB, Franck J, Hirsch S, et al. A randomized clinical trial of outpatient geriatric assessment (CGA), coupled with an intervention, to increase adherence to recommendations. J Am Ger soc. 1999;47:269–276.

    CAS  Google Scholar 

  59. Bula CJ, Berod AC, Stuck AE, et al. Effectiveness of preventive in-home geriatric assessment in well functioning, community dwelling older people: secondary analysis of a randomized trial. J Am Ger soc. 1999;47:389–395.

    CAS  Google Scholar 

  60. Balducci L, Yates G. General guidelines for the management of older patients with cancer. Oncology, NCCN Proc. November 14:2000;221–227.

    Google Scholar 

  61. Ingram SS, Seo PH, Martell RE, et al. Comprehensive assessment of the elderly cancer patient: The feasibility of self-report methodology. J Clin Oncol. 2002;20:770–775.

    Article  PubMed  Google Scholar 

  62. Balducci L, Extermann M, Meyer J, et al. Comprehensive geriatric intervention in older breast cancer patients. A pilot. Proc Am Soc Clin Oncol. 2001;20:314b (abstract 3008).

    Google Scholar 

  63. Hirdes JP, Frijters DH, Teare GF, et al. The MDS-CHESS Scale: a new measure to predict mortality in institutionalized older people. J Am Ger soc. 2003;51:96–100.

    Google Scholar 

  64. Stump TE, Callahan CM, Hendrie HC, et al. Cognitive impairment and mortality in older primary care patients. J Am Ger Soc. 2001;49:934–940.

    CAS  Google Scholar 

  65. Blazer DG, Hybels CF, Pieper CF. The association of depression and mortality in elderly persons: a case for multiple independent pathways. J Gerontol Med sci. 2001;56: M505–M509.

    CAS  Google Scholar 

  66. Saliba D, Elliott M, Rubenstein LZ, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Ger soc. 2001;49:1691–1699.

    CAS  Google Scholar 

  67. Gill TM, Baker DI. Gottschalk M, et al. A program to prevent functional decline in physically frail elderly persons who live at home. N Engl J med. 2002;347:1068–1074.

    Article  PubMed  Google Scholar 

  68. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, et al. Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol Med sci. 2001;56:M448–M453.

    CAS  Google Scholar 

  69. Njergovan V, man-Son-Hing M, Mitchell SL, et al. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol. 2001;56 A:M638–M643.

    Google Scholar 

  70. Kivela S-L, Pahakala K. Depressive disorders as predictors of physical disability in old age. J Am Ger soc. 2001;49:290–296.

    CAS  Google Scholar 

  71. Brody KK, Johnson RE, Ried LD, et al. A comparison of two methods for identifying frail medicare aged persons. J Am Ger soc. 2002;50:562–569.

    Google Scholar 

  72. Cohen HJ, Pieper CF, Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community-dwelling elderly. J Am Ger soc. 2001;49:S1, A3.

    Google Scholar 

  73. Taaffe DR, Harris TB, Ferrucci L, et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur Studies of successful aging. J Gerontol Med sci. 2000;55A:M709–M715.

    CAS  Google Scholar 

  74. Knickman JR, Snell EK. The 2030m problem: caring for aging baby boomers. Health Serv Res. 2002;37:849–884.

    Article  PubMed  Google Scholar 

  75. Nolan M. Successful ageing: keeping the person in person centred care. Br J Nurs. 2001;10:450–454.

    CAS  PubMed  Google Scholar 

  76. Dossey L. Longevity. Altern Ther Health med. 2002;8:12–16.

    Google Scholar 

  77. Tinker A. The social implications of an aging population. Mech Ageing Dev. 2002;123:729–735.

    Article  PubMed  Google Scholar 

  78. Karner TX. Caring for an aging society. J Aging Social Policy. 2001;13:15–36.

    CAS  Google Scholar 

  79. White H, McConnell E, Clipp E, et al. A randomized controlled trial of the psychosocial impact of providing internet training and access to older adults. Aging Mental Health. 2002;6:213–221.

    Google Scholar 

  80. Czaja SJ, Rubert MP. Telecommunications technology as an aid to family caregivers of persons with dementia. Psychosom med. 2002;64:469–476.

    PubMed  Google Scholar 

  81. Wilson LS, Gill RW, Sharp IF, et al. Building the hospital without walls: a CSIRO home telecare initiative. Telemed J. 2000;6:275–281.

    Article  CAS  PubMed  Google Scholar 

  82. Octavio Paz: el labirinto de la soledad

    Google Scholar 

  83. Repetto L, Balducci L. A case for geriatric oncology. Lancet Oncol. 2002;3:289–297.

    Article  PubMed  Google Scholar 

  84. Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol. 2000;18:1709–1717.

    CAS  PubMed  Google Scholar 

  85. Monfardini S, Carbone A. Non-Hodgkin’s lymphomas. In: Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology. London: Harwood Academic Publishers, 1998;577–595.

    Google Scholar 

  86. Balducci L, Beche C. Prevention of cancer in the older person. Clin Ger med. 2002;18:723–738.

    Google Scholar 

  87. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis, JAMA. 1995;273:149–154.

    CAS  Google Scholar 

  88. Walsh JME, Terdiman JI. Colorectal cancer screening: scientific evidence. J Am Med Ass. 2003;281:1288–1296.

    Google Scholar 

  89. Mccarthy EP, Burns RB, Freund KM, et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Ger soc. 2000;48:1226–1233.

    CAS  Google Scholar 

  90. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comor-bidity on the survival of older women with breast cancer. J Am Ger soc. 2002;50:1061–1068.

    Google Scholar 

  91. Walter LC, Covinsky CE. Cancer screening in elderly patients. J Am Med Ass. 2001;285:2750–2756.

    CAS  Google Scholar 

  92. Kemeny MM, Bush-Devereaux E, Merriam LT, et al. Cancer surgery in the elderly. Hematol/Oncol Clin N Am. 2000;14:169–192.

    CAS  Google Scholar 

  93. Davila Miguel. Anesthesia in older cancer patients. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology 2nd ed. Amsterdam: Harwood Academic Publishers; 2003, in press.

    Google Scholar 

  94. Olmi P, Ausili Cefaro GP, Balzi M, et al. radiotherapy in the aged. Clin Ger med. 1997;13:143–168.

    CAS  Google Scholar 

  95. Scalliet P, Pignon T. Radiotherapy in the elderly. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive Geriatric Oncology, London: Harwood Academic Publishers; 1998; 421–428.

    Google Scholar 

  96. Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin N Am., 2000;14:131–167.

    Article  CAS  Google Scholar 

  97. Balducci L and Trotti A. Organ preservation: an effective and safe form of cancer treatment. Clin Ger med. 1997;13:185–202.

    CAS  Google Scholar 

  98. Cova D, Balducci L. Cytotoxic chemotherapy in the older patient. In: Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology. 2nd ed. Amsterdam: Harwood Academic Publishers; 2003; in press.

    Google Scholar 

  99. Balducci L, Carreca I. Oral chemotherapy of cancer in the elderly. Am J Cancer 2002;1:101–108.

    Google Scholar 

  100. Lancet JE, Willman CL, Bennett JM. Acute myelogenous leukemia and aging: clinical interactions. Hematol/Oncol Clinics N Am. 2000;16:251–268.

    Google Scholar 

  101. Rudd GN, Hartley GA, Souhani RL. Persistence of cisplatin-induced interstrand crosslink-ing in peripheral blood mononuclear cells from elderly and younger individuals. Cancer Chemother Pharmacol. 1995;35:323–326.

    CAS  PubMed  Google Scholar 

  102. Zinzani PG, Storti S, Zaccaria A, et al. Elderly aggressive histology non-Hodgkin’s lymphoma: First line VNCOP-B regimen: expereince on 350 patients. Blood. 1999;94:33–38.

    CAS  PubMed  Google Scholar 

  103. Sonneveld P, de Ridder M, van der Lelie H, et al. Comparison of doxorubicin and mitox-antrone in the treatment of elderly patients with advanced diffuse non-Hodgkin’s lymphoma using CHOP vs CNOP chemotherapy. J Clin Oncol. 1995;13:2530–2539.

    CAS  PubMed  Google Scholar 

  104. Gomez H, Mas L, Casanova L, et al. Elderly patients with aggressive non-Hodgkin’s lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity. J Clin Oncol. 1998;16:2352–2358.

    CAS  PubMed  Google Scholar 

  105. Tirelli U, Eirante D, Van Glabbeke M, et al. CHOP is the standard regimen in patients ≥ 70 years of age with intermediate and high grade non-Hodgkin’s lymphoma: results of a randomized study of the European organization for the research and treatment of cancer lymphoma cooperative study. J Clin Oncol. 1998;16:27–34.

    CAS  PubMed  Google Scholar 

  106. Bastion Y, Blay J-Y, Divine M, et al. Elderly patients with aggressive non-Hodgkin’s lymphoma: disease presentation, response to treatment and survival. A Groupe d’Etude des Lymphomes de l’Adulte Study on 453 patients older than 69 years. J Clin Oncol. 1997;15:2945–2953.

    CAS  PubMed  Google Scholar 

  107. Bertini M, Freilone R, Vitolo U, et al. The treatment of elderly patients with aggressive non-Hodgkin’s lymphomas: feasiblity and efficacy of an intensive multidrug regimen. Leukemia Lymphoma. 1996;22:483–493.

    CAS  PubMed  Google Scholar 

  108. Reilly SE, Connors JM, Howdle S, et al. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. J Clin Oncol. 1993;2250–2257.

    Google Scholar 

  109. Armitage JO, Potter JF. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. J Am Ger soc. 1984;32:269–273.

    CAS  Google Scholar 

  110. Bjorkholm M, Osby E, Hagberg H, et al. Randomized trial of R-methu granulocyte colony stimulating factors as adjunto to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin’s lymphoma. Proc ASH, Blood (suppl). 1999;94:599a (abstract 2665).

    Google Scholar 

  111. Balducci L, Lyman GH, Ozer H. Patients aged ≥ 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy. J Clin Oncol. 2001;19:1583–1585.

    CAS  PubMed  Google Scholar 

  112. Balducci L, Hardy CH, Lyman GH. Hematopoietic growth factors in the older cancer patient. Curr Opin in Hematol. 2001;8:170–187.

    CAS  Google Scholar 

  113. Dees EC, O’Reilly S, Goodman SN, et al. A prospective pharmacologic evaluation of age-related toxicity chemotherapy in women with breast cancer. Cancer Invest. 2000; 18:521–529.

    CAS  PubMed  Google Scholar 

  114. Kim YJ, Rubenstein EB, Rolston KV, et al. Colony-stimulating factors (CSFs) may reduce complications and death in solid tumor patients with fever and neutropenia. Proc ASCO. 2000;19:612a (abstract 2411).

    Google Scholar 

  115. Begg C, Carbone P. Experience of the Eastern Cooperative Oncology Group. Cancer. 1983;52:1986–1992.

    CAS  PubMed  Google Scholar 

  116. Christman K, Muss HB, Case D, et al. Chemotherapy of metastatic breast cancer in the elderly. JAMA. 1992;268:57–62.

    Article  CAS  PubMed  Google Scholar 

  117. Giovannozzi-Bannon S, Rademaker A, Lai G, et al. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials. An Illinois Cancer Center study. J Clin Oncol 1994;12:2447–2452.

    Google Scholar 

  118. Ibrahim N, Frye DK, Buzdar AU, et al. Doxorubicin based combination chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Intern med. 1996;156:882–888.

    Article  CAS  PubMed  Google Scholar 

  119. Ibrahim NK, Buzdar AU, Asmar 1, et al. Doxorubicin based adjuvant chemotherapy in elderly breast cancer patients: the M D Anderson experience with long term follow-up. Ann Oncol. 2000;11:1–5.

    Article  Google Scholar 

  120. Gelman RS, Taylor SG. Cyclophosphamide, methotrexate and 5 fluorouracil chemotherapy in women more than 65 year old with advanced breast cancer. The elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol. 1984;2:1406–1414.

    Google Scholar 

  121. Stein BN, Petrelli NJ, Douglass HO, et al. Age and sex are independent predictors of 5-fluorouracil toxicity. Cancer. 1995;75:11–17.

    CAS  PubMed  Google Scholar 

  122. Jacobson SD, Cha S, Sargent DJ, et al. Tolerability, dose intensity and benefit of 5FU based chemotherapy for advanced colorectal cancer (CRC) in the elderly. A North Central Cancer Treatment Group Study. Proc Am Soc Clin Oncol. 2001;20:384a (abstract 1534).

    Google Scholar 

  123. Spielberger RT, Stiff P, Emmanouilides C, et al. Efficacy of recombinant human ker-atinocyte growth factor (rHuKGF) in reducing mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenito cell transplantation after radiation-based conditioning. Results of a phase 2 trial. Proc Am Soc Clin Oncol. 2001;20:7a (abstract 25).

    Google Scholar 

  124. Repetto L, Carreca I, Maraninchi D, et al. Use of growth factors in elderly patients with cancer: a report from the second international Society of Geriatric Oncology (SIOG) meeting. Crit Rev Hematol Oncol. 2003;45:123–128.

    Google Scholar 

  125. Ambady N, Koo J, Rosenthal R, Winograd CH. Physical therapists’ nonverbal communication predicts geriatric patients’ health outcomes. Psychol Aging. 2002;17(3):443–445.

    Article  PubMed  Google Scholar 

  126. Nolan M. Ageism: what is in a word? J Adv Nurs. 2003;41:8–93.

    PubMed  Google Scholar 

  127. Palmore E. The ageism survey: first findings. Gerontologist. 2001;41:572–575.

    CAS  PubMed  Google Scholar 

  128. Dunlop DD, Manheim LM, Song J, et al. Gender and ethnic/racial disparities in health care utilization among older adults. J Gerontol B Psychol sci. 2002;57:S221–S233.

    Google Scholar 

  129. Glanz K, Croyle RT, Chollett VY, et al. Cancer-related health disparity in women. Am J Publ Health. 2003:93:292–298.

    Google Scholar 

  130. Patriseck AC, Laliberte LL, Allen SM, et al. The treatment decision making process: age differences in a sample of women recently diagnosed with non-recurrent, early stage breast cancer. Gerontologist. 1997;37:598–608.

    Google Scholar 

  131. Kearney N, Miller M, Paul J, Smith K. Oncology healthcare professionals’ attitudes toward elderly people. Ann Oncol. 2000;11(5):599–560.

    Article  CAS  PubMed  Google Scholar 

  132. Won A, Lapane K, Gambassi G, et al. Correlates and management of nonmalignant pain in the nursing home. SAGE study group. Systematic assessment of geriatric drug use via epidemiology. J Am Ger soc. 1999;47:936–942.

    CAS  Google Scholar 

  133. Weitzen S, Teno JM, Fennell M, et al. Factors associated with site of death: a National study of where people die. Med Care. 2003;41:323–325.

    Article  PubMed  Google Scholar 

  134. Fox SA, Roetzheim RG, Kington RS. Barriers to cancer prevention in the older person. In: Balducci L, Lyman GH, Ershler WB eds. Comprehensive geriatric Oncology. Amsterdam; Harwood Academic Publishers, 1998;351–362.

    Google Scholar 

  135. Hutchins Hutchins I.F, Linger JM, Crowley JJ, et al. L. Underepresentation of patients 65 years of age and older in cancer treatment. N Engl J med. 1999;341:2061–2067.

    Google Scholar 

  136. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21(7):1383–1389.

    Article  PubMed  Google Scholar 

  137. Peake MD, Thompson S, Lowe D, et al. Ageism in the management of lung cancer. Age Ageing. 2003;32:171–177.

    Article  PubMed  Google Scholar 

  138. Kemeny M, Muss HB, Kornblith AB, et al. Barriers to participation of older women with breast cancer in clinical trials. Proc Am Soc Clin Oncol. 2000;19:602a (abstract 2371).

    Google Scholar 

  139. Fox SA, Stein JA, Sockloskie RJ, et al. Targeted mailed materials and the medicare beneficiary: increasing mammogram screening among the elderly. Am J Publ Health. 2002;92:805–810.

    Google Scholar 

  140. Markens S, Fox SA, Taub B, et al. Role of black churches in health promotion programs: lessons from the Los Angeles mammography promotion in churches program. Am J Publ Health. 2002;92:805–810.

    Google Scholar 

  141. Maly RC, Leake B, Silliman RA. Health care disparities in older patients with breast carcinoma: informational support from physicians. Cancer. 2003;97(6):1517–1527.

    Article  PubMed  Google Scholar 

  142. Arias E. United States life tables 2000. Natl Vital Stat Rep. 2002;51:1–38.

    PubMed  Google Scholar 

  143. Lillie-Blanton M, Brodie M, Rowland D, et al. Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 2000;57(suppl 1):218–235.

    PubMed  Google Scholar 

  144. Levine RS, Foster JE, Fullilove RE, et al. Black-white inequalities in mortality and life-expectancy, 1933–1999: implication for healthy people 2010. Publ Health Rep. 2001; 116:474–483.

    CAS  Google Scholar 

  145. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis.

    Google Scholar 

  146. Levkoff S, Sanchez H. Lessons learned about minority recruitment and retention from the centers of minority aging and health promotion. Gerontologist. 2003;43:18–26.

    PubMed  Google Scholar 

  147. Galambos CM, Moving cultural diversity toward cultural competence in health care. Health Soc Work 2003;28:3–7.

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Balducci, L., Johnson, D., Beghe, C. (2004). Cancer and Aging. In: Moore, R.J., Spiegel, D. (eds) Cancer, Culture, and Communication. Springer, Boston, MA. https://doi.org/10.1007/0-306-48007-7_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-48007-7_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47885-7

  • Online ISBN: 978-0-306-48007-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics